Furthermore, we performed quantitative real-time PCR (qRT-PCR) of our clinical samples to confirm that UNC93B1 were high-expressed in AML-M4/M5 FAB subtypes (p < 0.005, Figure 1I). Here, UNC93B1 is linked to acute myeloid leukemia.